Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

CNTACNTA
Showing 7 of 15 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in CENTESSA PHARMACEUTICALS PLC

Janus Henderson Group Ltd. holds 3.5M shares of CNTA (CENTESSA PHARMACEUTICALS PLC), worth $138.7M as of 2026-Q1. The position was decreased (-14.7% shares). CNTA represents 0.1% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$138.7M

Current Shares

3.5M

Total Value Change

+$118M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
3.5M
-14.7%
$138.7M0.1%$26.20
0
2025-Q4
Decreased
4.1M
-24.3%
$102.4M0.0%$24.74
0
2025-Q3
Decreased
5.4M
-17.2%
$131.1M0.1%$24.40
0
2025-Q2
Increased
6.5M
+10.3%
$85.8M0.0%$13.13
33
2025-Q1
Increased
5.9M
+20.6%
$86.4M0.0%$14.59
36
2024-Q4
Increased
4.9M
+279.1%
$82.2M0.0%$16.35
48
2024-Q3
New
1.3M
-
$20.7M0.0%$15.79
39

Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used